Cogentix Medical has championed percutaneous tibial nerve stimulation (PTNS) since 2004, working closely with key opinion leaders to determine best practices in how to incorporate Urgent PC into clinical practice. We pride ourselves on this treatment’s evolution and accomplishments, and want to continue to be a reference for you. We will continue to support you with product experts with unparalleled knowledge of PTNS who work with you to determine how to best incorporate Urgent PC into your practice.
We provide a wide variety of tools that you can use to facilitate your Urgent PC program within your practice, including patient brochures, consent forms and voiding diaries. The patient brochures provide information for your patients to know how Urgent PC works, patient testimonials, and how they can receive treatment. The patient consent forms is a means to easily collect signed consent for treatment and includes an overview of PTNS from the treatment set-up, settings, and schedules. The voiding dairies will provide a simple tool for your patients to track their symptoms and voiding history.
These tools have been developed over the last decade with input from our valuable customers. We’re always looking for ways to make them even more useful to our customers and our patients.
Medicare, and many other payers, cover PTNS with Urgent PC for Overactive Bladder (OAB) and associated symptoms of urge incontinence, urinary frequency, and urgency of urination.
There are multiple sources we provide to answers any questions you may have about reimbursement. To learn more about PTNS coverage you can refer to the Urgent PC Reimbursement Guide. For more information on who covers PTNS you can refer to our PTNS Coverage Finder. You can also talk to your territory manager, or contact the Cogentix Reimbursement Department.
We’re committed to ensuring that our customers’ Urgent PC programs continue to succeed. Utilizing our marketing programs will help expand the use of Urgent PC, a treatment that’s good for your patients, and good for your practice.
Urgent PC has been proven through its clinical data and experience. If there are still questions, ideas, or topics you would like us to cover, please contact your territory manager, or leave a comment below.
Urgent PC is indicated for the treatment of Overactive Bladder and associated symptoms of urinary urgency, urinary frequency and urge incontinence. Treatment with Urgent PC is contraindicated for patients with pacemakers or implantable defibrillators, patients prone to excessive bleeding, patients with nerve damage that could impact either percutaneous tibial nerve or pelvic floor function or patients who are pregnant or planning to become pregnant during the duration of the treatment. Most patients don't experience side-effects. If side-effects occur, they are typically temporary and include mild pain and skin inflammation at or near the stimulation site. Caution: Federal law (USA) restricts this device to sale by or on the order of a physician. For complete instructions for use, storage, warnings, indications, contraindications, precautions, adverse reactions and disclaimer of warranties, please refer to the insert accompanying each product or online at www.cogentixmedical.com. Urgent PC is a registered trademark of Cogentix Medical © 2016 Cogentix Medical. All rights reserved.